FBN’s Liz MacDonald on deal stocks under pressure as the U.S. announces stricter tax rules.
Former CBO director Doug Holtz-Eakin and Morgan Stanley Wealth Management Head Lisa Shalett on the business and policy environment around mergers and acquisitions.
Glenmede Director of Investment Strategy Jason Pride on where to find growth in the current market, Russia’s economy, international and emerging markets.
FBN’s Liz MacDonald, Marshall Auerback of the Institute for New Economic Thinking, and Convergent Wealth Advisors CEO David Zier on exclusive details on a government group reaping the benefits of tax deserters..
ALR Technologies president Bill Smith on the government’s proposed rule that would allow doctors to get paid for non-face-to-face care.
FBN’s Liz MacDonald on President Obama’s demand for economic patriotism from companies moving business overseas.
FOX News contributor Bernie Goldberg on media coverage of the Israel-Gaza conflict, Jon Stewart and Eric Holder.
Former Bain Capital managing director Ed Conard and The Vanguard Group CEO Bill McNabb on businesses parking cash overseas.
International Chamber of Commerce chairman Harold ‘Terry’ McGraw III says the U.S. is not competitive to attract investment.
U.S. Congressional candidate Claudia Tenney and Swiss America Trading Chairman Craig Smith on businesses’ efforts to reduce their tax burden.
FBN’s Jo Ling Kent on Medtronic ’s deal for Covidien.
Money Map Press’ Keith Fitz-Gerald, FBN’s Nicole Petallides and Liz MacDonald on the markets, the crisis in Iraq, oil, gasoline prices, Michael Kors and Medtronic ’s acquisition of Covidien.
FOX Business contributor Bob Rice breaks down inversion tactics.
FBN’s Lauren Simonetti on EMCORE’s sale of its space solar division, Integra LifeSciences’ deal with Medtronic and Sonic Drive-In.
Delphi Management Founder and president Scott Black gives his big stock picks.
FBN’s Liz MacDonald with a look at the biggest offshore cash piles.
FBN’s Lou Dobbs on Burger King’s deal to buy Canada’s Tim Hortons.
Belpointe Asset Management Chief Strategist David Nelson, FBN’s Charles Payne, retail analyst Hitha Prabhakar, Penn Financial Group founder Matt McCall and FBN’s Tracy Byrnes debate the outlook for Edwards Lifesciences.
Earnings HQ: FBN’s Lori Rothman breaks down Medtronic ’s first-quarter earnings report.
Jason Pride, director of investment strategy at Glenmede, offers stocks to watch.